-2%
Gliclazide is employed to reduce blood sugar levels in type 2 diabetes mellitus when diet, exercise, and weight reduction are insufficient. It is combined with diet and exercise to enhance blood sugar control in adults with type 2 diabetes.
Admira 80mg Tablet falls under the category of “oral hypoglycemic” drugs and is employed to manage type 2 diabetes mellitus when diet and exercise alone fail to control blood sugar levels. This condition, characterized by impaired glucose processing in the body, often affects individuals who do not produce enough insulin or display insulin resistance (when insulin doesn’t function effectively). Commonly known as adult-onset diabetes, type 2 diabetes mainly affects middle-aged or older individuals.
Containing gliclazide, Admira 80mg Tablet operates by enhancing pancreatic insulin release. This action boosts insulin secretion, reducing blood sugar levels and preventing excessive spikes. Adhering to the prescribed dose and duration is crucial for optimal outcomes. Possible side effects include stomach discomfort, indigestion, nausea, diarrhea, and constipation, which generally diminish over time.
Ceasing Admira 80mg Tablet independently is discouraged, as it can elevate blood sugar levels, inviting complications like vision impairment, kidney damage, and limb loss. Prior to commencing the medication, inform your doctor about pregnancy, breastfeeding plans, or any history of heart, liver, or kidney diseases, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and hemolytic anemia. Alcohol consumption while taking Admira 80mg Tablet should be avoided to mitigate side effects (hypoglycemia). Disclose all medications and health conditions to your doctor to prevent adverse effects.
For optimum effectiveness, combine Admira 80mg Tablet with a health-conscious lifestyle, encompassing weight loss for those with a BMI >25, reduced calorie intake (limiting fatty and sugary foods), and increased physical activity (at least 150 minutes weekly).